ACCOR/ FR0000120404 /
- - | Изменение - | Объем сделки | Бид3:00:58 | Предложение3:00:58 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
39.120EUR | - | - Оборот: - |
-Величина цены спроса: - | -Величина цены предложения: - | 10.32 млрдEUR | 3.02% | 17.52 |
GlobeNewswire
10:38
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improveme...
GlobeNewswire
10:30
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire
10:11
AMERICAN SALARS FILES NI 43-101 TECHNICAL REPORT ON BLACKROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
9:16
Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
GlobeNewswire
9:11
Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
GlobeNewswire
8:07
Hitachi Energy to invest additional $4.5 billion by 2027 to accelerate the clean energy transition
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница